ACCENDRA HEALTH INC.
Registrant: ACCENDRA HEALTH INC. · 2026 3rd Quarter (July 1 - Sep 30)
$200,000
Total organization expenses, all reported topics
Medicare/Medicaid
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Lobbyists named: FAITH A. CRISTOL
Congress inferred from reporting year; verify the bill reference in the source.
